Goldman Sachs SELL

Friday Fodder Diving into 2Q26 Earnings Setups

Jul 24, 2026

From the report报告摘录GLP-1 Script Growth: Obesity scripts breach 1.2m weekly (9% w/w), Wegovy TRx +15% w/w (169.7k), starter doses +25% w-o-w; Zepbound Kwikpen TRx accelerates to 140k (vs.

Read the full report + PDF阅读全文与 PDF

The full summary (5 key points) and the original Goldman Sachs PDF are for MastermindX Pro members. 完整摘要（5 个要点）与 Goldman Sachs 原始 PDF 为 MastermindX Pro 会员专享。

Read on MastermindX前往 MastermindX 阅读

Related institutional research相关机构研报

Not investment advice. MastermindX hosts third-party institutional research for reference and education; ratings and views are the authors', not ours. Browse the full Research Vault → 非投资建议。MastermindX 仅收录第三方机构研究，供参考与学习；其中评级与观点均属作者本人。浏览完整研报库 →